I haven’t put in the research time for ICT140 because 107 is front and center now that results are coming up, Yu said on the last call that it would take awhile for the enrollment of 140 to be completed and I’m building another portfolio.
But my poor understanding of ICT140 is another shotgun approach and I could be wrong here but this key ingredient targeting EphA2 that IMUC got from Upitt in March 2012 hasn’t been tested yet.
This mixture targeting EphA2 seems like the thing that makes IMUC’s ICT140 product much different than everyone else’s.
So in order to research ICT140 I think the article entitled “Emerging strategies for EphA2 receptor targeting for cancer therapeutics” by Tandon and Vemula that can also be found free of charge on the NIH gov website and has some nice easy to understand slides and is an easy read that everyone can understand EphA2.
An issue I have with this study and dealing with EphA2 is the autoimmune response that was brought up at the end of that 2011 study:
"Pneumococcal vaccination revealed substantial immune suppression, even in patients in remission. Rational design of consolidative strategies for ovarian cancer will need to overcome tolerance and immunosuppression"
And the other problems I have with this EphA2 approach is that the mechanism isn’t understood by scientists and there are other ways to approach the EphA2 issue explained by that article.
So we’ll see where this all leads and hopefully it works out ok.
Both articles can be found at ncbi nlm nih gov
we'll see, but that's a risk you have to think about when investing in these companies south of the border.
im in this around 12 but looking at valuation still looks good. nobody needed JPM to tell you that. its still cheap near 14 but yes, the political uncertainty is something you have to worry about.
i would suggest someone that doesn't follow the mining sector to look at one of the larger more diversified miners that are still cheap.
just make a list of stocks that you might be interested in, wait for an offering to get rid of all the plastic, fake traders and weak hands and buy.
I've been on this board for a little over a year and only a few people are still here, well at least under the same name.
no. lol i have no idea about this dentist or whatever your're talking about and im not kidding.
is this part of those accusations you brought up something like last year and I proved all of them to be full of nonsense?
i really have to thank you because it really altered my outlook on stocks and made me really take the time to research my picks and to rely on myself.rather than others, so thanks.
Although your posts were full of nonsense i learned something lol from the interaction.
"There's only one reason for a CEO to pump so hard to retailers and "
thats utter nonsense, Seeking Alpha has been pumping this stock without telling retail any of the negatives of the company the last few months.
this stock went up over $3 on trial results and then fell back under $3 shorty afterwards. this was the long lasting effects of the CEO pump you are taling about, it was short lived.
It has only gone over $3 without trial esults from the hype increase from Seeking Alpha writers the last few months.
gameplan hasnt changed since grabbing the bulk of my holding in oct/nov 2012 well under $2. I'm holding for the results of aldoxorubicin, no matter what happens and I really dont care about anything else.
Everytime CYTR is up you change to that other ID or disappear but a little hiccup comes up and mrshashaberry shows up. lolol im here all the time and take everything in stride, on good days and bad, its all meaningless until the results come.
No CEO, zippo on a reverse split, upcoming quarter near. nothing really going on here, so just waiting and watching.
OOOh they did bring in someone with a dermatological background very nice. but still waiting for further improvements.
A factor to figuring out this offering price of a traditional offering includes the net tangible book value of shares that brings the offering price down considerably from the market price. You can Google a basic formula for figuring out a Secondary offering price.
This low price is of course a drawback of doing a traditional offering. An ATM would have been more stockholder friendly but it would have taken many months to receive the money from an offering.
Its basically about how fast CYTR needs money, a traditional offering provides imminent funding vs an ATM that gets sold slowly over time.
The only issue that I would look at here with this offering is that CYTR has a few upcoming catalysts in the near term and would have provided good times to sell into without really crushing shareholder value, so I could view it as either mismanagement or management being too conservative .
The flip side of this argument is if the trial update is negative then it would be even worse trying to do another offering after bad news than doing an offering now. So you could also see it as protecting long term investors also. so there are two sides of the story.
The CEO/CFOs Kriegsman/Caloz seem “old school” in their procedures and favor the traditional offering opposed to the ATMs shown by how they operate.
And Kriegsman owns a big percentage of the float and has a huge amount of stock options so the guy isn’t going out of his way to shoot himself in the foot. Just look that info up on the ceo via SEC filings. So its not really like hes trying to kill stockholders, its just the way he does business and ignored setting up an ATM a few months ago.
It will be announced via press release/announcenment by CYTR when the offering is closed. So check the newswires or the CYTR website every few days.
I suggest you look at CYTR's 424B5 SEC filing- its an offering prospectus and will provide more info about CYTR's offering than relying on other people's opinions.
The 424B5 would normally have the specific date but the current one doesn't have the specific date filled in when the offering should be closed but it is expected to be done this month.
But you can look at the last 424B5 filing i think its in OCT2012 and see that similiar offering of i think 8 or 9 million shares took a week or so to close.
OOh and the SEC filings can easily be found at the NASDAQ site just type in CYTR and on the left side towards the very bottom is SEC Filing tab.
And OOh, there isn't something called a "stupid question" when it comes to finding out info on potential investments.
eh, i guess they could have done an ATM.
But the stock is on the higher side of the price range while over $3 and they need money for all the tests and trials coming up. I haven't taken the time to figure out how much these items are to really say "the CEO did wrong". but i would have preferred the ATM.
but if it wasn't that i might have been something else so. . whatever. if you liked it over $3, no idea why anyone wouldn't like it cheaper.
With the cash and short term investments there's still well over $20M on hand.
But this was an issue i had with this stock and that's the accounting behind the short term investments and the whats going on with these short term investments.
With these, the balance sheet looks like there's well over 20 M, but without it, there's only 10M on hand.
But i ignored it because I'm used to the high volatility.
Eh, we'll see what happens, but the stock has gone to $3 a few times this year and I don't see why it wont do it again in the next few months, especially if some test results are good, but a lot of people involved in this stock are lacking the bear side of this stock. and need to do some RESEARCH.
And please stay away from those Seeking Alpha writers.
they're too slllloooooow to deal with this business environment and they've spread themselves out too fast without the necessary financial funding/support.
dont blame anyone but yourself.
all you had to do is look at a 1 year chart and see the crazy volatility of this stock. Its shot up to 3 and back down into the 2s a few times.
if you weren't willing to endure the swings, i have no idea what you're doing here.
Use research to combat fear and stay away from one sided Seeking Alpha articles.
yeah, do you want to help me get a rental car? lololol
I will address this quickly.
And this is assuming this post you made is out of anger of what I told that poster about they might be otherwise better off in some other less risky asset other than IMUC right now because they don’t know how to look up how much a cash a company has on hand on a balance sheet and look at a burn rate.
It wasn’t to insult anyone, I know what you’re talking about though, I’ve seen some mean spirited posts by people that try to demean folks that aren’t informed on what’s going and try to prevent them from posting on the board by trying to make them feel bad about not having a clue. But I was trying to be being honest and not trying to be spiteful.
Apparently I struck a nerve, lolol and that wasn’t my intention, so I apologize to anyone that was offended. If I came over as some overbearing know it all then, I was wrong and I didn’t mean to come across this way. I was just genuinely concerned about someone putting themselves into a situation that do no fully understand.
Regardless of someone’s knowledge of stocks or biotech or whatever you ALL have something to contribute to the IMUC conversation. If you or I are wrong, oh well, we’re wrong, but I’m sure we’ll get a better grasp of what we’re thinking by writing ideas down and throwing them out to others ie actively engaging in investing and someone reading your post might be able to use your contribution in their investment plan also, so everyone wins.
Anyway, this thread was written out of anger/spite and will not be productive in any manner so I will apologize once again and look forward to engaging you and others on the board in a more open minded productive manner keeping my criticisms to myself and helping if I can like I should have in the other thread. Good luck.
I gave the original poster the answer as to where and what to look for. I wasn’t disrespectful or childish but honest so you or anyone can take it for what it is. I know this is a site for jokers and children but once in a while I’ll find someone who is genuinely serious and care about where they place their money so I try my best to be as professional as I can, I lapse sometimes lololol but in general I take everyone serious and just block the jokers.
I disagree with you on a few points but I would say to you that this information that you believe to be elusive is easily available if you are uptodate on the happenings of a company and actively thinking about your investment. So I suggest you stay awhile, actively engage posters and question everything you read.
As for your post, I disagree with your assessment and I suggest you listen to the last conference call concerning management’s ideas on proceding with the FDA IF the results are favorable.
I also would recommend you put together a possible scheduling of upcoming IMUC important events, something that many companies include in their presentations ie dates of possible drug data, catalysts etc then figure out the burn rate and how much is on the books. This should give a better idea of how many offerings or better ideas of a company's financial standing down the line in the year or so than just giving this blanket statement that every biotech needs funding and has to be done xyz etc etc like what you gave.
Im not going to make this post longer, but a few of us on this board were able to figure out the IMUC ATM about a month before the offering was made official from a newswire about IMUC management meeting with an investment firm that deals heavily in offerings so yeah it can be done by other means than just balance sheet analysis.
p.s. your math isn't right concerning how much IMUC has or I should say will have in the upcoming months. And again, please refer to the last conference call
All I can do is wish you the best of luck putting your hard earned cash with THEIR picks because we all know they care about how you do. LOLOL
If you know enough about the stocks they promote, you will know these authors purposely leave out important information. I recently glanced at a Smith article and was so happy, so happy, that people were actively questioning his work in the comments section. Great job.
All I’m suggesting that I wish people would become more informed in what their putting their hard earned money into and don’t rely on the aforementioned writers or anyone and I mean anyone except yourself.
3 of 3
I’ve been reading a few posts of yours but few really write anything serious anymore. I said that I wasn’t writing anything serious on this board and I haven’t, I just come to see if people have news. If people want to be manipulated by the Shane Blackmons, Larry Smiths, Scott Matusows, Brian Nichols or whoever you follow, be my guest, but you get what you put in and people looking at their your holding to see if its up 5 cents or down 5 cents and not trying to understand why they are up/down, doesn’t count towards research.
This is a complex situation and people that have a simple gameplan are more than likely going to get hurt because they’re not putting in the time or not paying attention. This isn’t the time where you can just jump in and ride the express straight to a new house or whatever your goal is, nope not yet. I wrote when that time comes here.
Going back to the original poster, I would again tell them to stay clear of this stock or tread lightly in IMUC until they have more serious questions and more knowledge about what they are thinking about investing in. Asking about a potential offering tells me they’re not up to date on current events from the ATM offering. So again I would say do more research and get active with meaningful questions on this board. Then decide for yourself.
2 of 3
And to be honest, if someone doesn’t know the ins and out of this company and doesn’t have the experience to recognize a bargain when they see it, they will break at the downward pressure and sell when they should be buying. Either they have #$%$ portfolio management skills or don’t know what’s going on. We saw this recently with the IMUC longs second guessing themselves and bailing when IMUC went to $2 then shot up over $3.
There are also too many retail investors here that can be easily manipulated by a simple Seeking Alpha writer who doesn’t have a clue but wants to move the stock price. This was why I tried to talk about IMUC issues here on the yahoo board months ago to stay ahead of the BS Seeking Alpha/blogger manipulating articles but retail drowned out the real posters here.
1 0f 3
Since you’ve been here awhile but more importantly, you post meaningful ideas, I’ll try to entertain you.
I definitely disagree with your risk/reward ratio analysis because if I’m not mistaken, IMUC’s approach of dealing with IL-13Ra2 is in more than 1 drug candidate in IMUC’s pipeline. So if ICT107 doesn’t work well, the pipeline is dead and this stock will be in pain.
If a potential investor isn’t willing to go long and I mean well past the upcoming results. . .which is up in the air of course, they're not going to make a lot but will be risking a lot more. The real money will come after the results come out (if they are favorable of course) and after the traders and Cantor sell into the news and depress share price.
Retail will be asking why is the stock down when/if the results are favorable but there will be too many sellers waiting for the event, ie the Cantor folks. Now, what if a Seeking Alpha writer like everyone’s favorite biotech blogger Scott Matusow does what he did to AGEN with IMUC in addition to the Cantor offering?
Scott wrote an article that news was imminent on a trial and told everyone they should buy into the stock, well, everyone bought shares up a few days before the news hit and dumped all the shares when the results came and the longs were left scratching their heads as to what happened. Its just too many sellers were waiting for the news and the same thing is here at IMUC where all you see is “when are the results coming? When are the results coming?” And less on what’s actually happening with the company.